Market Overview:
The global pulmonary edema treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of pulmonary edema, increasing awareness about the disease, and technological advancements in the field of diagnosis and treatment. However, lack of reimbursement for certain treatments and high cost of treatment are some factors that may restrain the growth of this market during the forecast period. On the basis of type, the global pulmonary edema treatment market is segmented into diagnosis and treatment. The diagnostic segment is further sub-segmented into imaging techniques (X-ray computed tomography [CT], magnetic resonance imaging [MRI], ultrasound) and blood tests (pulmonary function test [PFT], arterial blood gas analysis). The therapeutic segment is further sub-segmented into drug therapy (diuretics, vasodilators), mechanical ventilation, oxygen therapy, surgery/endoscopic procedures), and other therapies (nutritional support). On the basis on application, hospitals & clinics accounted for majority share in 2017 owing to rising number Pulmonary Edema cases across globe coupled with availability advanced technologies for diagnosis & Treatment . However , academic institutes are projected to witness highest CAGR over next 10 years due icting growing demand for better healthcare facilities among population along with initiatives taken by government authorities towards development education sector .
Product Definition:
Pulmonary edema is a condition that results when fluid accumulates in the lungs. The main symptom is shortness of breath. Treatment involves relieving the underlying cause and using medications to improve breathing. Pulmonary edema can be life-threatening if not treated.
Diagnosis:
Diagnosis is the process of determining whether a medical condition exists or not. In Pulmonary Edema Treatment (PERT), diagnosis plays an important role in deciding on treatment alternatives. Growth Factor Inhaled from outside the body by lungs to facilitate their expansion and breathing process, thus enabling oxygen uptake by tissues; it helps in increasing the ability of organs to function normally & carry out its intended task.
Treatment:
Treatment and it's usage in Pulmonary Edema Treatment market is used to reduce the excess fluid in the lungs. It helps to improve lung capacity and breathing. The treatment works by decreasing or removing the cause of fluid from the lungs, either through drainage or administration of drugs.
The global pulmonary edema treatment market was valued at over USD 1 billion in 2014.
Application Insights:
The market is segmented into hospitals and clinics, academic institutes, retail pharmacies, household caretakers and others. The hospitals and clinics segment dominated the global market in terms of revenue in 2017. This can be attributed to a large patient base with pulmonary edema as well as other respiratory disorders requiring treatment at hospitals or clinics. Pulmonary edema is also a common condition that requires emergency medical attention at hospital or clinic level which further contributes to the largest share of this segment.
The academic institutes segment is expected to grow significantly over the forecast period owing to rising awareness among healthcare professionals regarding effective treatment methods for different diseases including pulmonary edema.
Regional Analysis:
North America dominated the global pulmonary edema treatment market in 2017. This can be attributed to the presence of well-established healthcare infrastructure, high awareness levels coupled with a favorable reimbursement scenario. In addition, Pulmonary Embolism (PE) is one of the most common conditions leading to hospital admissions in this region. According to a study conducted by CDC’s National Center for Health Statistics and U.S.
Asia Pacific is expected witness lucrative growth over the forecast period owing to rising healthcare expenditure along with increasing government initiatives pertaining towards prevention.
Growth Factors:
- Increasing incidence of pulmonary edema
- Growing awareness about the treatment of pulmonary edema
- Rising demand for better and innovative therapies for pulmonary edema
- Technological advancements in the field of pulmonary edema treatment
- Availability of government funding for research and development in the field of pulmonary edema
Scope Of The Report
Report Attributes
Report Details
Report Title
Pulmonary Edema Treatment Market Research Report
By Type
Diagnosis, Treatment
By Application
Hospitals and Clinics, Academic Institutes, Retail Pharmacies, Household, Other
By Companies
Pfizer Inc (US), ARGON MEDICAL (US), Edwards Lifesciences Corporation (US), BD (US), Alcaliber S.A. (Spain), Lupin Pharmaceuticals (India), Vitaltec Corporation (China), Medtronic (US), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (US), Canon Medical Systems Corporation (Japan)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
229
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Pulmonary Edema Treatment Market Report Segments:
The global Pulmonary Edema Treatment market is segmented on the basis of:
Types
Diagnosis, Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Academic Institutes, Retail Pharmacies, Household, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc (US)
- ARGON MEDICAL (US)
- Edwards Lifesciences Corporation (US)
- BD (US)
- Alcaliber S.A. (Spain)
- Lupin Pharmaceuticals (India)
- Vitaltec Corporation (China)
- Medtronic (US)
- Koninklijke Philips N.V. (The Netherlands)
- Siemens Healthcare (Germany)
- Hitachi Medical Corporation (US)
- Canon Medical Systems Corporation (Japan)
Highlights of The Pulmonary Edema Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnosis
- Treatment
- By Application:
- Hospitals and Clinics
- Academic Institutes
- Retail Pharmacies
- Household
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pulmonary Edema Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pulmonary edema is a medical emergency that can occur when fluid accumulates in the lungs. Treatment typically includes aggressive hydration and oxygen therapy. In some cases, surgery may be necessary to remove the fluid buildup.
Some of the major players in the pulmonary edema treatment market are Pfizer Inc (US), ARGON MEDICAL (US), Edwards Lifesciences Corporation (US), BD (US), Alcaliber S.A. (Spain), Lupin Pharmaceuticals (India), Vitaltec Corporation (China), Medtronic (US), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare (Germany), Hitachi Medical Corporation (US), Canon Medical Systems Corporation (Japan).
The pulmonary edema treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pulmonary Edema Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pulmonary Edema Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pulmonary Edema Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pulmonary Edema Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pulmonary Edema Treatment Market Size & Forecast, 2018-2028
4.5.1 Pulmonary Edema Treatment Market Size and Y-o-Y Growth
4.5.2 Pulmonary Edema Treatment Market Absolute $ Opportunity
Chapter 5 Global Pulmonary Edema Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pulmonary Edema Treatment Market Size Forecast by Type
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pulmonary Edema Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pulmonary Edema Treatment Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Academic Institutes
6.2.3 Retail Pharmacies
6.2.4 Household
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pulmonary Edema Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pulmonary Edema Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pulmonary Edema Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Pulmonary Edema Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pulmonary Edema Treatment Market Size Forecast by Type
9.6.1 Diagnosis
9.6.2 Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pulmonary Edema Treatment Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Academic Institutes
9.10.3 Retail Pharmacies
9.10.4 Household
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pulmonary Edema Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Pulmonary Edema Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pulmonary Edema Treatment Market Size Forecast by Type
10.6.1 Diagnosis
10.6.2 Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pulmonary Edema Treatment Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Academic Institutes
10.10.3 Retail Pharmacies
10.10.4 Household
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pulmonary Edema Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pulmonary Edema Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pulmonary Edema Treatment Market Size Forecast by Type
11.6.1 Diagnosis
11.6.2 Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pulmonary Edema Treatment Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Academic Institutes
11.10.3 Retail Pharmacies
11.10.4 Household
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pulmonary Edema Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Pulmonary Edema Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pulmonary Edema Treatment Market Size Forecast by Type
12.6.1 Diagnosis
12.6.2 Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pulmonary Edema Treatment Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Academic Institutes
12.10.3 Retail Pharmacies
12.10.4 Household
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pulmonary Edema Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pulmonary Edema Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pulmonary Edema Treatment Market Size Forecast by Type
13.6.1 Diagnosis
13.6.2 Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pulmonary Edema Treatment Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Academic Institutes
13.10.3 Retail Pharmacies
13.10.4 Household
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pulmonary Edema Treatment Market: Competitive Dashboard
14.2 Global Pulmonary Edema Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc (US)
14.3.2 ARGON MEDICAL (US)
14.3.3 Edwards Lifesciences Corporation (US)
14.3.4 BD (US)
14.3.5 Alcaliber S.A. (Spain)
14.3.6 Lupin Pharmaceuticals (India)
14.3.7 Vitaltec Corporation (China)
14.3.8 Medtronic (US)
14.3.9 Koninklijke Philips N.V. (The Netherlands)
14.3.10 Siemens Healthcare (Germany)
14.3.11 Hitachi Medical Corporation (US)
14.3.12 Canon Medical Systems Corporation (Japan)
